Have symptoms of Early Alzheimer's disease. (Diagnosis of Early Alzheimer's Disease or Mild Cognitive Impairment is not required)
Have a study partner who is willing to participate in the study and attend some study visits
About the Study:
Early Alzheimer's disease causes slight but noticeable problems with memory, thinking and behavior that may or may not affect daily life.
Trouble retaining new information
Frequently losing a wallet or keys
Neglecting to pay bills
Difficulty paying attention
Over time, Alzheimer's disease symptoms may occur more frequently or get worse. More severe symptoms include trouble doing routine tasks and changes in mood and personality. Although difficult to accept, identifying symptoms early lets you take advantage of available treatments, support and clinical trials.
The Aware Study is evaluating an investigational medication targeting the tau protein to see if it may slow the progression of Early Alzheimer's disease.
What is Involved:
If you qualify and decide to participate, you:
Will receive all study-related care and medication at no cost
May potentially help future Alzheimer’s research, treatment and those who suffer from the disease
Each study participant needs a study partner. The study partner should know the participant well and have frequent contact with him or her. They will be required to attend some study visits to answer questions about the participant's symptoms.
The study doctors and staff respect your privacy. We will not share information about your health with anyone who is not associated with this research study unless you have given us permission to do this or as required by law.